Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2022 Filed Jul 7, 2022 00:01 UTC |
Schick Joseph CDirector
|
GrantCommon Stock | 409 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-016766 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,138 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| July 01, 2022 Filed Jul 7, 2022 00:01 UTC |
Ellingson RachelDirector
|
GrantCommon Stock | 341 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-016765 · rdgdoc.xml · nonDerivative · entry 1 Ellingson Rachel · CIK 0001557271 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,382 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| July 01, 2022 Filed Jul 7, 2022 00:00 UTC |
GOSWAMI JOYDEEPDirector
|
GrantCommon Stock | 369 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-016763 · rdgdoc.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,380 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| June 28, 2022 Filed Jul 1, 2022 00:06 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 495 | $14.86 | $7,355.70 |
DisclosureSEC source: 0001437749-22-016326 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,446 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 28, 2022 Filed Jul 1, 2022 00:05 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 598 | $14.86 | $8,886.28 |
DisclosureSEC source: 0001437749-22-016325 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,236 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 28, 2022 Filed Jul 1, 2022 00:02 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 704 | $14.86 | $10,461.44 |
DisclosureSEC source: 0001437749-22-016324 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,015 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 28, 2022 Filed Jul 1, 2022 00:00 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 889 | $14.86 | $13,210.54 |
DisclosureSEC source: 0001437749-22-016323 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,452 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 24, 2022 Filed Jun 29, 2022 00:00 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 456 | $15.95 | $7,273.20 |
DisclosureSEC source: 0001437749-22-016098 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,799 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 19, 2022 Filed Jun 22, 2022 00:01 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 418 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-015534 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,255 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 19, 2022 Filed Jun 22, 2022 00:01 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 733 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-015533 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,719 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 19, 2022 Filed Jun 22, 2022 00:00 UTC |
Rice MichaelDirector · CEO
|
GrantCommon Stock | 899 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-015532 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,341 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 19, 2022 Filed Jun 22, 2022 00:00 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-015531 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,834 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 19, 2022 Filed Jun 22, 2022 00:00 UTC |
DE GREEF RODERICKCOO & President
|
GrantCommon Stock | 955 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-015530 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · COO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,716 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 05, 2022 Filed Jun 8, 2022 00:01 UTC |
DE GREEF RODERICKCOO & President
|
GrantCommon Stock | 957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014541 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · COO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,761 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 05, 2022 Filed Jun 8, 2022 00:01 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 498 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014540 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,337 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 05, 2022 Filed Jun 8, 2022 00:01 UTC |
Rice MichaelDirector · CEO
|
GrantCommon Stock | 901 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014539 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,442 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 05, 2022 Filed Jun 8, 2022 00:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 735 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014538 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,986 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 05, 2022 Filed Jun 8, 2022 00:00 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 419 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014537 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,837 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:03 UTC |
Schick Joseph CDirector
|
GrantCommon Stock | 374 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014309 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,729 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:02 UTC |
GOSWAMI JOYDEEPDirector
|
GrantCommon Stock | 343 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014308 · rdgdoc.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,011 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:01 UTC |
Ellingson RachelDirector
|
GrantCommon Stock | 311 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014307 · rdgdoc.xml · nonDerivative · entry 1 Ellingson Rachel · CIK 0001557271 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,041 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 4, 2022 00:00 UTC |
DuRoss AmyDirector
|
GrantCommon Stock | 343 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-014306 · rdgdoc.xml · nonDerivative · entry 1 DuRoss Amy · CIK 0001854968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,073 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of directors fees at the last closing price as of the date of grant. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:01 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 43 | $14.53 | $624.79 |
DisclosureSEC source: 0001437749-22-014060 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,418 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:01 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 174 | $14.53 | $2,528.22 |
DisclosureSEC source: 0001437749-22-014059 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,839 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:00 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 749 | $14.53 | $10,882.97 |
DisclosureSEC source: 0001437749-22-014058 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,541 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 351 | $14.53 | $5,100.03 |
DisclosureSEC source: 0001437749-22-014057 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,251 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 22, 2022 Filed May 25, 2022 00:04 UTC |
Wichterman TroyChief Financial Officer
|
GrantCommon Stock | 448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-013466 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,461 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| May 22, 2022 Filed May 25, 2022 00:03 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
GrantCommon Stock | 786 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-013465 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,602 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| May 22, 2022 Filed May 25, 2022 00:02 UTC |
Foster Karen A.Chief Quality Officer
|
GrantCommon Stock | 533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-013464 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,013 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| May 22, 2022 Filed May 25, 2022 00:01 UTC |
Rice MichaelDirector · CEO
|
GrantCommon Stock | 964 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-013463 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,290 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the at the last closing price as of the date of grant. Read SEC document |
| May 22, 2022 Filed May 25, 2022 00:00 UTC |
DE GREEF RODERICKCOO & President
|
GrantCommon Stock | 1,024 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-013462 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · COO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,804 F1 · price: The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. Read SEC document |
| May 13, 2022 Filed May 18, 2022 00:02 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 165 | $12.32 | $2,032.80 |
DisclosureSEC source: 0001437749-22-012850 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,326 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 13, 2022 Filed May 18, 2022 00:02 UTC |
Aebersold SarahVP, Global Human Resources
|
SaleCommon Stock | 40 | $12.32 | $492.80 |
DisclosureSEC source: 0001437749-22-012849 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · VP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,693 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 13, 2022 Filed May 18, 2022 00:01 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 108 | $12.32 | $1,330.56 |
DisclosureSEC source: 0001437749-22-012848 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,816 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 13, 2022 Filed May 18, 2022 00:01 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 41 | $12.32 | $505.12 |
DisclosureSEC source: 0001437749-22-012846 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,439 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 13, 2022 Filed May 18, 2022 00:01 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 58 | $12.32 | $714.56 |
DisclosureSEC source: 0001437749-22-012847 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,480 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 13, 2022 Filed May 18, 2022 00:01 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 51 | $12.32 | $628.32 |
DisclosureSEC source: 0001437749-22-012845 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,941 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 13, 2022 Filed May 18, 2022 00:00 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 125 | $12.32 | $1,540.00 |
DisclosureSEC source: 0001437749-22-012844 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,013 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 06, 2022 Filed May 11, 2022 00:02 UTC |
GOSWAMI JOYDEEPDirector
|
GrantCommon Stock | 14,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011806 · rdgdoc.xml · nonDerivative · entry 1 GOSWAMI JOYDEEP · CIK 0001533115 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,668 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and fully vests on the first anniversary of the grant date. Read SEC document |
| May 06, 2022 Filed May 11, 2022 00:01 UTC |
DuRoss AmyDirector
|
GrantCommon Stock | 14,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011804 · rdgdoc.xml · nonDerivative · entry 1 DuRoss Amy · CIK 0001854968 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,730 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and fully vests on the first anniversary of the grant date. Read SEC document |
| May 06, 2022 Filed May 11, 2022 00:01 UTC |
Ellingson RachelDirector
|
GrantCommon Stock | 14,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011803 · rdgdoc.xml · nonDerivative · entry 1 Ellingson Rachel · CIK 0001557271 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,730 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and fully vests on the first anniversary of the grant date. Read SEC document |
| May 06, 2022 Filed May 11, 2022 00:01 UTC |
Schick Joseph CDirector
|
GrantCommon Stock | 14,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-011802 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,355 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and fully vests on the first anniversary of the grant date. Read SEC document |
| April 21, 2022 Filed Apr 23, 2022 00:00 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 477 | $13.94 | $6,649.38 |
DisclosureSEC source: 0001437749-22-009566 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,480 F1 · kind: The sale reported herein was made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| April 21, 2022 Filed Apr 23, 2022 00:00 UTC |
Aebersold SarahVP, Global Human Resources
|
SaleCommon Stock | 325 | $13.94 | $4,530.50 |
DisclosureSEC source: 0001437749-22-009565 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · VP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,733 F1 · kind: The sale reported herein was made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 00:17 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 24,400 | $17.59 | $429,196.00 |
DisclosureSEC source: 0001437749-22-009264 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,491 F1 · date: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · kind: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · price: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 00:17 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 16,413 | $17.59 | $288,704.67 |
DisclosureSEC source: 0001437749-22-009263 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,538 F1 · date: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · kind: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · price: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 00:17 UTC |
DE GREEF RODERICKCOO & President
|
SaleCommon Stock | 18,530 | $17.59 | $325,942.70 |
DisclosureSEC source: 0001437749-22-009262 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · COO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,780 F1 · date: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · kind: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · price: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 00:16 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 13,581 | $17.59 | $238,889.79 |
DisclosureSEC source: 0001437749-22-009260 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,992 F1 · date: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · kind: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · price: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 00:16 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 19,325 | $17.59 | $339,926.75 |
DisclosureSEC source: 0001437749-22-009261 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,924 F1 · date: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · kind: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · price: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 00:15 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 286 | $17.59 | $5,030.74 |
DisclosureSEC source: 0001437749-22-009259 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,957 F1 · date: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · kind: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. F1 · price: The sales reported herein were made by a broker to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. The sales were made by the broker on April 13, 2022, April 14, 2022 and April 18, 2022. The high sales price during the period was $19.22, the low sales price during the period was $16.33 and the weighted average sales price was $17.59. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.